Dietary intake of flavonoids and oesophageal and gastric cancer: Incidence and survival in the United States of America (USA)

British Journal of Cancer

Volumn 112, Issue 7, 2015, Pages 1291-1300

  Petrick, J L ^a   Steck, S E ^b   Bradshaw, P T ^a   Trivers, K F ^c   Abrahamson, P E ^d   Engel, L S ^a   He, K ^e   Chow, W H ^f   Mayne, S T ^g   Risch, H A ^g   Vaughan, T L ^h   Gammon, M D ^a  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Salmon Bay Biologicals   (United States)

^e INDIANA UNIVERSITY   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g YALE UNIVERSITY   (United States)

^h USA   (United States)

Author keywords

Diet; Epidemiologic studies; Flavonoids; Gastric cancer; Oesophageal cancer; Survival

Indexed keywords

FLAVANONE DERIVATIVE; FLAVONE DERIVATIVE; FLAVONOID; FLAVONOL DERIVATIVE; ISOFLAVONE DERIVATIVE; LIGNAN; PROANTHOCYANIDIN;

ADULT; AGED; APPLE; ARTICLE; BANANA; BEAN; BEER; BLUEBERRY; BREAD; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; CARDIA; CELERY; CHICKEN MEAT; CHILE; COFFEE; CONTROLLED STUDY; DIETARY INTAKE; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; FRUIT JUICE; GRAPEFRUIT JUICE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; ONION; ORANGE (FRUIT); PINEAPPLE; PRIORITY JOURNAL; RISK REDUCTION; STOMACH ADENOCARCINOMA; STOMACH CANCER; TEA; UNITED STATES; VEGETABLE; WINE; CASE CONTROL STUDY; CLINICAL TRIAL; DIET; ESOPHAGEAL NEOPLASMS; FRUIT; INCIDENCE; MULTICENTER STUDY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; STOMACH NEOPLASMS; SURVIVAL;

CASE-CONTROL STUDIES; DIET; ESOPHAGEAL NEOPLASMS; FEMALE; FLAVONOIDS; FRUIT; HUMANS; INCIDENCE; MALE; RISK FACTORS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; UNITED STATES; VEGETABLES;

EID: 84938551089     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2015.25     Document Type: Article

References (48)

1. Aiyer HS, Li Y, Losso JN, Gao C, Schiffman SC, Slone SP, Martin RC (2011) Effect of freeze-dried berries on the development of reflux-induced esophageal adenocarcinoma. Nutr Cancer 63(8): 1256-1262.
2. Bhagwat S, Haytowitz DB, Holden JM (2008) U.S. Department of Agriculture, Agricultural Research Service. USDA Database for the Isoflavone Content of Selected Foods, Release 2.0.
3. Bhagwat S, Haytowitz DB, Holden JM (2011) U.S. Department of Agriculture, Agricultural Research Service. USDA Database for the Flavonoid Content of Selected Foods, Release 3.0.
4. Bobe G, Peterson JJ, Gridley G, Hyer M, Dwyer JT, Brown LM (2009) Flavonoid consumption and esophageal cancer among black and white men in the United States. Int J Cancer 125(5): 1147-1154.
5. Bravo L (1998) Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 56(11): 317-333.
6. Brown JE (2008) Nutrition Through the Life Cycle. 3rd edn. Thomson/ Wadsworth: Belmont, CA.
7. D'Archivio M, Filesi C, Di Benedetto R, Gargiulo R, Giovannini C, Masella R (2007) Polyphenols, dietary sources and bioavailability. Ann Ist Super Sanita 43(4): 348-361.
8. de Martel C, Forman D, Plummer M (2013) Gastric cancer: epidemiology and risk factors. Gastroenterol Clin North Am 42(2): 219-240.
9. Devesa SS, Blot WJ, Fraumeni JF Jr (1998) Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83(10): 2049-2053.
10. Drossard C, Frohling B, Dietrich H, Kersting M (2011) Anthocyanin analysis in banana fruit-A mistake. Am J Clin Nutr 93(4): 865-866, author reply 866-7.
11. Ekstrom AM, Serafini M, Nyren O, Wolk A, Bosetti C, Bellocco R (2011) Dietary quercetin intake and risk of gastric cancer: results from a population-based study in Sweden. Ann Oncol 22(2): 438-443.
12. El-Serag HB, Satia JA, Rabeneck L (2005) Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers. Gut 54(1): 11-17.
13. Falk GW (2009) Risk factors for esophageal cancer development. Surg Oncol Clin N Am 18(3): 469-485.
14. Freedman ND, Murray LJ, Kamangar F, Abnet CC, Cook MB, Nyren O, Ye W, Wu AH, Bernstein L, Brown LM, Ward MH, Pandeya N, Green AC, Casson AG, Giffen C, Risch HA, Gammon MD, Chow WH, Vaughan TL, Corley DA, Whiteman DC (2011) Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium. Gut 60(8): 1029-1037.
15. Gammon MD, Schoenberg JB, Ahsan H, Risch HA, Vaughan TL, Chow WH, Rotterdam H, West AB, Dubrow R, Stanford JL, Mayne ST, Farrow DC, Niwa S, Blot WJ, Fraumeni JF Jr (1997) Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 89(17): 1277-1284.
16. Harnly JM, Doherty RF, Beecher GR, Holden JM, Haytowitz DB, Bhagwat S, Gebhardt S (2006) Flavonoid content of U.S. fruits, vegetables, and nuts. J Agric Food Chem 54(26): 9966-9977.
17. Hernandez-Ramirez RU, Galvan-Portillo MV, Ward MH, Agudo A, Gonzalez CA, Onate-Ocana LF, Herrera-Goepfert R, Palma-Coca O, Lopez-Carrillo L (2009) Dietary intake of polyphenols, nitrate and nitrite and gastric cancer risk in Mexico City. Int J Cancer 125(6): 1424-1430.
18. Hongo M, Nagasaki Y, Shoji T (2009) Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol 24(5): 729-735.
19. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KAe. SEER Cancer Statistics Review, 1975-2010, National Cancer Institute. Bethesda, MD. http://seer.cancer. gov/csr/1975-2010/, based on November 2012 SEER data submission, posted to the SEER web site, April 2013. Accessed 16 December 2013.
20. Huang WY, Cai YZ, Zhang Y (2010) Natural phenolic compounds from medicinal herbs and dietary plants: potential use for cancer prevention. Nutr Cancer 62(1): 1-20.
21. Ko AH, Dollinger M, Rosenbaum EH (2008) Everyone's Guide to Cancer Therapy: How Cancer Is Diagnosed, Treated, and Managed Day to Day. Rev. 5th edn. Andrews McMeel Pub: Kansas City.
22. Kresty LA, Frankel WL, Hammond CD, Baird ME, Mele JM, Stoner GD, Fromkes JJ (2006) Transitioning from preclinical to clinical chemopreventive assessments of lyophilized black raspberries: interim results show berries modulate markers of oxidative stress in Barrett's esophagus patients. Nutr Cancer 54(1): 148-156.
23. Kristal AR, Feng Z, Coates RJ, Oberman A, George V (1997) Associations of race/ethnicity, education, and dietary intervention with the validity and reliability of a food frequency questionnaire: the Women's Health Trial Feasibility Study in Minority Populations. Am J Epidemiol 146(10): 856-869.
24. Lagiou P, Samoli E, Lagiou A, Peterson J, Tzonou A, Dwyer J, Trichopoulos D (2004) Flavonoids, vitamin C and adenocarcinoma of the stomach. Cancer Causes Control 15(1): 67-72.
25. Li B, Jiang G, Zhang G, Xue Q, Zhang H, Wang C, Zhao T (2014) Intake of vegetables and fruit and risk of esophageal adenocarcinoma: a meta-analysis of observational studies. Eur J Nutr 53(7): 1511-1521.
26. Lunet N, Valbuena C, Vieira AL, Lopes C, David L, Carneiro F, Barros H (2007) Fruit and vegetable consumption and gastric cancer by location and histological type: case-control and meta-analysis. Eur J Cancer Prev 16(4): 312-327.
27. Mayne ST, Risch HA, Dubrow R, Chow WH, Gammon MD, Vaughan TL, Farrow DC, Schoenberg JB, Stanford JL, Ahsan H, West AB, Rotterdam H, Blot WJ, Fraumeni JF Jr (2001) Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 10(10): 1055-1062.
28. Navarro Silvera SA, Mayne ST, Risch H, Gammon MD, Vaughan TL, Chow WH, Dubrow R, Schoenberg JB, Stanford JL, West AB, Rotterdam H, Blot WJ, Fraumeni JF Jr (2008) Food group intake and risk of subtypes of esophageal and gastric cancer. Int J Cancer 123(4): 852-860.
29. Pierini R, Kroon PA, Guyot S, Ivory K, Johnson IT, Belshaw NJ (2008) Procyanidin effects on oesophageal adenocarcinoma cells strongly depend on flavan-3-ol degree of polymerization. Mol Nutr Food Res 52(12): 1399-1407.
30. Rossi M, Garavello W, Talamini R, La Vecchia C, Franceschi S, Lagiou P, Zambon P, Dal Maso L, Bosetti C, Negri E (2007) Flavonoids and risk of squamous cell esophageal cancer. Int J Cancer 120(7): 1560-1564.
31. Rossi M, Rosato V, Bosetti C, Lagiou P, Parpinel M, Bertuccio P, Negri E, La Vecchia C (2010) Flavonoids, proanthocyanidins, and the risk of stomach cancer. Cancer Causes Control 21(10): 1597-1604.
32. Rothman KJ (1990) No adjustments are needed for multiple comparisons. Epidemiology 1(1): 43-46.
33. Rothman KJ, Greenland S, Lash TL (2008) Modern Epidemiology. 3rd edn. Wolters Kluwer Health/Lippincott Williams & Wilkins: Philadelphia.
34. Schwartz GK, Ilson D, Saltz L, O'Reilly E, Tong W, Maslak P, Werner J, Perkins P, Stoltz M, Kelsen D (2001) Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma. J Clin Oncol 19(7): 1985-1992.
35. Shaheen N, Ransohoff DF (2002) Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review. JAMA 287(15): 1972-1981.
36. Simard EP, Ward EM, Siegel R, Jemal A (2012) Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin 62(2): 118-128.
37. Spencer JP, Abd El Mohsen MM, Minihane AM, Mathers JC (2008) Biomarkers of the intake of dietary polyphenols: strengths, limitations and application in nutrition research. Br J Nutr 99(1): 12-22.
38. Stoner GD, Chen T, Kresty LA, Aziz RM, Reinemann T, Nines R (2006) Protection against esophageal cancer in rodents with lyophilized berries: potential mechanisms. Nutr Cancer 54(1): 33-46.
39. Sun CL, Yuan JM, Lee MJ, Yang CS, Gao YT, Ross RK, Yu MC (2002) Urinary tea polyphenols in relation to gastric and esophageal cancers: a prospective study of men in Shanghai, China. Carcinogenesis 23(9): 1497-1503.
40. Thompson LU, Boucher BA, Liu Z, Cotterchio M, Kreiger N (2006) Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan. Nutr Cancer 54(2): 184-201.
41. Trivers KF, De Roos AJ, Gammon MD, Vaughan TL, Risch HA, Olshan AF, Schoenberg JB, Mayne ST, Dubrow R, Stanford JL, Abrahamson P, Rotterdam H, West AB, Fraumeni JF, Chow WH (2005) Demographic and lifestyle predictors of survival in patients with esophageal or gastric cancers. Clin Gastroenterol Hepatol 3(3): 225-230.
42. U.S. Patent Office. Extract from Ginkgo biloba leaves, its method of preparation and pharmaceuticals containing the extract. http:// patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d =PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l= 50&s1=5,399,348.PN.&OS=PN/5,399,348&RS=PN/5,399,348, Accessed 9 July 2013.
43. Vermeulen E, Zamora-Ros R, Duell EJ, Lujan-Barroso L, Boeing H, Aleksandrova K, Bueno-de-Mesquita HB, Scalbert A, Romieu I, Fedirko V, Touillaud M, Fagherazzi G, Perquier F, Molina-Montes E, Chirlaque MD, Vicente Arguelles M, Amiano P, Barricarte A, Pala V, Mattiello A, Saieva C, Tumino R, Ricceri F, Trichopoulou A, Vasilopoulou E, Ziara G, Crowe FL, Khaw KT, Wareham NJ, Lukanova A, Grote VA, Tjonneland A, Halkjaer J, Bredsdorff L, Overvad K, Siersema PD, Peeters PH, May AM, Weiderpass E, Skeie G, Hjartaker A, Landberg R, Johansson I, Sonestedt E, Ericson U, Riboli E, Gonzalez CA (2013) Dietary flavonoid intake and esophageal cancer risk in the European prospective investigation into cancer and nutrition cohort. Am J Epidemiol 178(4): 570-581.
44. Waksberg J (1978) Sampling methods for random digit dialing. J Am Stat Assoc 73: 40-46.
45. Wijnhoven BP, Siersema PD, Hop WC, van Dekken H, Tilanus HW (1999) Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Oesophageal Tumour Study Group. Br J Surg 86(4): 529-535.
46. Willett W (2012) Nutritional Epidemiology. Vol. third. Oxford University Press: New York.
47. Willett WC, Howe GR, Kushi LH (1997) Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 65(4 Suppl): 1220S-1228S discussion 1229S-1231S.
48. Zamora-Ros R, Agudo A, Lujan-Barroso L, Romieu I, Ferrari P, Knaze V, Bueno-de-Mesquita HB, Leenders M, Travis RC, Navarro C, Sanchez-Cantalejo E, Slimani N, Scalbert A, Fedirko V, Hjartaker A, Engeset D, Skeie G, Boeing H, Forster J, Li K, Teucher B, Agnoli C, Tumino R, Mattiello A, Saieva C, Johansson I, Stenling R, Redondo ML, Wallstrom P, Ericson U, Khaw KT, Mulligan AA, Trichopoulou A, Dilis V, Katsoulis M, Peeters PH, Igali L, Tjonneland A, Halkjaer J, Touillaud M, Perquier F, Fagherazzi G, Amiano P, Ardanaz E, Bredsdorff L, Overvad K, Ricceri F, Riboli E, Gonzalez CA (2012) Dietary flavonoid and lignan intake and gastric adenocarcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr 96(6): 1398-1408.